go to http://www.aocs.org! Algaetech International — The Future is NowComplete Algae Monitoring System Visit  cricatalyst.com!Nexus — Leaders in Greenhouse Systems Integration

Innovations

Mosquitoes from the genus Anopheles transmit the protozoan that causes malaria.

Mosquitoes from the genus Anopheles transmit the protozoan that causes malaria.

On Developing an Algal-based Cure for Malaria

June 17, 2012, by Dr. Stephen Mayfield
AlgaeIndustryMagazine.com

Over the past ten years, work from our lab has identified mechanisms of chloroplast gene expression that have allowed for development of recombinant protein expression and metabolic engineering in the algal chloroplast.

Transformation of algae is relatively easy. You can transform either the nuclear or the chloroplast genome. If you get DNA in, and you have a good selectable marker and a good selection system, you can get transformation.

There are rather complex structures that fold into three-dimensional RNA elements that are bound by protein factors, and that is a requirement for translation. We still haven’t sorted this all out, but we’ve identified a number of elements that are required, and a number of proteins that interact in order to get translation.

Having accumulated these proteins and showing that they were bioactive, we went back to ask, “What’s the advantage of expressing something inside of a chloroplast, or inside of an algae? What biological advantages does that give you over expressing the protein in a bacterial or a mammalian cell culture?”

So one of the things that the lab came up with was to try and express malarial proteins. And the reason we wanted to express these was because malarial proteins have many different domains inside of them, folded in very complex proteins. Malaria is a euchariotic parasite, and their proteins form complex structures that have many disulfite bonds, but the proteins are not glycosolated.

That’s important because when you try to express these proteins in bacterial systems, they are incapable of doing the complex fold and they won’t form disulfate bonds. If you’re trying to express these in mammalian systems, they’ll form the disulfite bonds and correctly fold them, but then they decorate the proteins with sugar—they glycosolate them—so that if you use these as a vaccine, you end up getting antibodies to the sugars rather than the proteins.

Mayfield Lab team (L to R): Javier Gimpel, Dan Barrera, Liz Specht, Beth Rasala, Jamie Gregory, Stephen Mayfield, Carla Jones, Mike Hannon, Trang Le, Miller Tran, Julie Kim, Crystal Warning

Mayfield Lab team (L to R): Javier Gimpel, Dan Barrera, Liz Specht, Beth Rasala, Jamie Gregory, Stephen Mayfield, Carla Jones, Mike Hannon, Trang Le, Miller Tran, Julie Kim, Crystal Warning

So, we knew that inside of chloroplasts—inside of all plastids—we could fold complex proteins. We could make disulfate bonds. But we also knew there was no mechanism to glycosolate these. So we expressed three different surface antigens, PFS-25, 28 and 45. All of those proteins accumulate very well inside the chloroplast. Importantly, they all fold correctly. So then, antibodies directed against native proteins, which only recognize the correctly folded native proteins, also recognized the algal-expressed proteins.

Most importantly, when we injected these proteins into mice, the mice-generated antibodies recognized the correctly folded proteins, and we had an immune response. Those antibodies blocked malaria transmission within the mice.

It’s important to understand, for something like malaria, that most recombinant vaccines today cost about a hundred dollars a dose, and generally you need two or three injections. So clearly for the people in the malaria belt—and there are about two billion people on this planet in the malaria belt—they simply do not have the resources to even think about spending two or three hundred dollars for a vaccine.

I think these developments using algal proteins are beginning to give us the opportunity to make those vaccines cheap enough that we can think about the real possibility of inoculating two billion people.

A co-founder of the San Diego Center for Algae Biotechnology (SD-CAB), and Sapphire Energy, Dr. Mayfield is Professor of Molecular Biology, and the John Dove Isaacs Chair of Natural Philosophy, at UC San Diego.

More Like This…

Go to HOME Page

Copyright ©2010-2012 AlgaeIndustryMagazine.com. All rights reserved. Permission required to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

From The A.I.M. Archives

— Refresh Page for More Choices
Heliae, SCHOTT North America and Arizona State University (ASU) have announced a partnership to bring Heliae’s algae production technology to ASU’s algae testbed facility...
University of Adelaide researchers are using nanotechnology and the fossils of diatoms to develop a novel chemical-free and resistance-free way of protecting stored grain...
Solazyme, Inc. has announced results for the fourth quarter and full year ended December 31, 2013. “2013 was a year of great progress for Solazyme as we readied our first...
Valensa International and Contract Biotics have announced that Contract Biotics has started construction of an additional six acres of algae production units at the compa...
One of 12 winners of the 2014 Lexus Design Award, the Ooho algae balloon was created by three London-based designers to contribute a solution to the rising number of plas...
Algae is being discussed at the heart of EXPO Milano 2015, the international event that has existed since 1851, spawning world shaping themes and icons, such as the Eiffe...
Students from three Arizona universities will demonstrate their algae research projects at an Innovation Showcase May 1, in Arizona State University’s Sun Devil Fitness C...
A series of articles by Stephen Mayfield and the UCSD Laboratory deserve recognition for their articles on algae-based medicines for malaria and cancer. Mayfield and his ...
A team of six University of Calgary researchers has been awarded funding for their project, Cost Effective Biotechnology for Carbon Capture and Re-Use, based on the conce...
By sending algae into space, a U.S. Department of Agriculture (USDA) scientist and his team will be able to study some of the key mechanisms that control plant growth and...
In Phys.Org, Yu Yonehara notes the breakthrough research from the Tokyo Institute of Technology on the connection between early marine algae and the development of terres...
Four years after the first optimistic calculations, the experimental cultivation of algae at Wageningen University in the Netherlands appears to be meeting expectations. ...
A University of New South Wales (UNSW)-led team of researchers has discovered how algae that survive in very low levels of light are able to switch on and off a weird qua...
The Guardian reports that Prince Edward Island (P.E.I.), Canada-based Solarvest has created an inventive system utilizing a specific algal strain to grow and produce EPA ...
Gilbert, AZ-based Heliae has announced a partnership with Sincere Corporation, a Japanese waste management and recycling company, to form a joint venture and develop a co...
Algae Industry Magazine is pleased to announce a new Algae 101 series by our popular blogger, Mark Edwards, Professor, Arizona State University. The Algae Solutions to Na...
Steven Mufson reports for the Washington Post that Algenol Biofuels estimates hackers have attempted to break into its computers 39 million times in four months this year...
In an effort to propel the algae industry forward, the Algae Testbed Public Private Partnership (ATP3) offers a series of hands-on specialized workshops suited for partic...